Chronic, recurrent Lymphocytic Leukemia Recruiting Phase 1 Trials for Filgrastim (DB00099)

Also known as: Recurrent Chronic Lymphocytic Leukemia

IndicationStatusPhase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02960646Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment